Breaking News
November 19, 2017 - Retinal sensitivity linked to cognitive status in T2DM
November 19, 2017 - Dental filling failure linked to smoking, drinking and genetics
November 19, 2017 - Medicaid expansion takes a bite out of medical debt
November 19, 2017 - Study aims to involve parents in early intervention services for children with autism
November 19, 2017 - Don’t Fret Delays in Treating Colon Cancer, Study Suggests
November 19, 2017 - Yeast Infection Test: MedlinePlus Lab Test Information
November 19, 2017 - Video of blood clot contraction reveals how platelets naturally form unobtrusive clots
November 19, 2017 - UNN researchers explore modeling of cognitive dissonance phenomenon
November 19, 2017 - Verseon presents second anticoagulation candidate for clinical trials at AHA 2017
November 19, 2017 - Pregnant Asian women who develop high blood pressure at highest risk for heart failure hospitalization
November 19, 2017 - Medicare seeks comment on ways to cut costs of Part D drugs
November 19, 2017 - Tree cover linked to fewer asthma cases in polluted urban neighborhoods
November 19, 2017 - Make the Diagnosis: Hair Care Conundrum
November 19, 2017 - New techniques give blood biopsies greater promise
November 19, 2017 - Researchers identify possible genetic basis for coronary artery disease
November 19, 2017 - Stress experienced by emergency call handlers has negative impact on psychological health
November 18, 2017 - New cancer cell screening is improving childhood leukaemia treatment
November 18, 2017 - Groundbreaking study identifies protein as potential factor in cancer metastasis
November 18, 2017 - New model to test effectiveness of existing and potential CF therapies
November 18, 2017 - Staying Active May Lower Odds for Glaucoma
November 18, 2017 - Potential new autism drug shows promise in mice
November 18, 2017 - Some states roll back ‘retroactive Medicaid,’ a buffer for the poor — and for hospitals
November 18, 2017 - Selectively deleting stem cell factor promotes recovery after TBI in mice
November 18, 2017 - Breakthrough research brings new procedure closer to helping patients with blood cancer
November 18, 2017 - Dr Peter Simpson Appointed to SLAS Board of Directors
November 18, 2017 - Friendships between young children can protect against ADHD
November 18, 2017 - Old World monkeys could hold key to stop progression of rheumatoid arthritis
November 18, 2017 - Harris Health System RNs named among 20 Outstanding Nurses for 2017
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study shows how naïve T-cells may affect tumor immunity and immunotherapy
November 18, 2017 - New studies highlight importance of cardiorespiratory fitness to reduce CVD risk
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - Leaf-eating ability of beetle largely due to bacteria inside the insect
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
Ohio’s drug-pricing ballot question triggers voter confusion

Ohio’s drug-pricing ballot question triggers voter confusion

image_pdfDownload PDFimage_print

Lawmakers in the nation’s capital have yet to grapple with rising drug costs, but Ohio voters are being asked — in a single ballot-box question next week — to figure out how best to lower the tab the state pays for prescriptions.

The Drug Price Relief Act, better known as Ohio Issue 2, has been promoted and pilloried in a dizzying crush of robocalls, TV and radio ads, and direct mailings.

Opponents say it is impossible to implement, could limit patients’ access to medicines and would not necessarily save money. Proponents are selling the initiative as a rebellion that could save millions of dollars in an era of health care anxiety.

And, as Election Day approaches, voters say it’s difficult to make sense of it all.

Sean Hundley, a 30-year-old Medicaid beneficiary who works at a coffee shop in Columbus’ trendy Short North neighborhood, said he has seen plenty of advertising from both sides, but he can’t figure out who is telling the truth.

“Everything they say, not knowing who to trust — it would just lead me not to cast a vote,” he said.

This reaction highlights one of the difficulties of tasking voters with sorting out such a complex issue. But what they decide will likely have implications well beyond the state’s borders.

In the absence of federal action, states have begun taking legislative steps to address the toll of rising drug costs on their budgets — a trend that raises concerns among pharmaceutical companies.

If Issue 2 passes, this ballot-question strategy may also gain momentum. Advocates in South Dakota and the District of Columbia are already pushing for such a drug pricing initiative in the November 2018 election.

But California voters rejected a similar measure last year, noted Jane Horvath, a senior policy fellow at the National Academy for State Health Policy. A second failure could have a chilling effect on the idea of using the ballot to push drug-pricing reform, she added.

That’s part of the reason why this ballot-question campaign has drawn attention and contributions from outside the state. Supporters have raised more than $14 million, with most of that money coming from the California-based AIDS Healthcare Foundation. Opponents, bankrolled by the pharmaceutical industry, have raised $58 million.

But during a recent water aerobics class at a suburban Cincinnati gym, participants — mostly women who said they were reading daily newspaper coverage and watching local news to figure out how to vote on the ballot initiative — said they were fed up with all of the campaign noise.

The exercisers — fit, mostly retirees bouncing up and down in the water — even peppered a reporter with questions: Do you understand it? Can you explain it to me?

If enacted, Issue 2 would prohibit state programs, such as Medicaid and state employee health plans, from paying more for a medication than does the federal Veterans Health Administration. The Department of Veterans Affairs receives heavily reduced prices for prescription drugs.

But analysts are divided over whether this would work, or what amount of relief it could provide to the state budget.

An analysis by the nonpartisan Ohio Office of Budget and Management said it’s unclear whether the change would actually save any money and, if so, how much.

Supporters, who include Vermont Sen. Bernie Sanders and Ohio’s former Republican Party chairman, counter that their calculations indicate savings of about $400 million — and that, they say, is why drug companies have spent so much fighting the initiative.

“Our opponents say it’s unworkable or — they’ve created a word — ‘unimplementable.’ We believe it will work,” said Dennis Willard, a spokesman for the Yes on 2 campaign.

Meanwhile, critics worry Issue 2 would be nearly impossible to enforce.

For one thing, the VA’s final discounts are deemed proprietary and kept secret. For another, it’s unclear which state agencies would be included under the initiative.

In addition, the state’s Medicaid program already receives discounts from drug companies. Unlike the VA, though, federal law requires it to cover the vast majority of drugs, making price negotiation more difficult.

“You can’t get the VA prices if you don’t do VA things,” said Walid Gellad, co-director of the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. “To just say, ‘We’re not going to pay more than the VA’ is difficult.”

But those are nuances that are tough to explain in a radio spot, or on a mailed flyer. And that means the dueling media blitz is leaving many Ohio voters at a loss.

Take Barbara Herr, a 64-year-old paralegal. She’s a lifelong Democrat, she said, and in some ways the issue’s target voter: a self-described “political junkie” who voted for Sanders in his presidential campaign.

She has a shellfish allergy so she carries an EpiPen — a medication for which drugmaker price hikes sparked national scorn and a congressional hearing. Even though the ballot question would not likely directly affect her medication spending, she thinks prescription drug pricing is a “grave concern” and must be addressed.

So far, though, she’s a likely no vote.

“It just is very confusing,” Herr said, reflecting on her impending Election Day decision. “I have read quite a bit about it, and I don’t think it achieves much of anything.”

In some ways, experts said, this response is to be expected.

Drug pricing is complex and already has caused head-scratching among policymakers and academics, noted Rachel Sachs, an associate professor of law at Washington University in St. Louis, who studies the issue. In a recent congressional hearing, lawmakers struggled to identify the key source of price spikes, or the best place to attempt regulation.

“Confusion is a very normal thing to feel when looking at this,” Sachs said. “And a concern I might have is whether the parties on either side, when they’re spending on advertisements — either for or against the initiative — are really seeking to stoke that confusion.”

KHN’s coverage of prescription drug development, costs and pricing is supported in part by the Laura and John Arnold Foundation.

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Tagged with:

About author

Related Articles